Activity of melflufen in RR MM patients with extramedullary disease in the phase 2 HORIZON study (OP-106): Promising results in a high-risk population Meeting Abstract


Authors: Richardson, P. G.; Mateos, M. V.; Rodríguez-Otero, P.; Norkin, M.; Larocca, A.; Hassoun, H.; Alegre, A.; Paner, A.; Leleu, X.; Maisel, C.; Mazumder, A.; Harmenberg, J.; Byrne, C.; Zubair, H.; Thuresson, S.; Blade, J.
Abstract Title: Activity of melflufen in RR MM patients with extramedullary disease in the phase 2 HORIZON study (OP-106): Promising results in a high-risk population
Meeting Title: 17th International Myeloma Workshop
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 19
Issue: 10 Suppl.
Meeting Dates: 2019 Sep 12-15
Meeting Location: Boston, MA
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2019-10-01
Start Page: e352
End Page: e353
Language: English
ACCESSION: 139238136
DOI: 10.1016/j.clml.2019.09.582
PROVIDER: EBSCOhost
PROVIDER: cin20
DOI/URL:
Notes: Meeting Abstract: OAB-86 -- Accession Number: 139238136 -- Entry Date: In Process -- Revision Date: 20191023 -- Publication Type: Article -- Supplement Title: Oct2019 Supplement -- Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101525386. -- Source: cin20
Altmetric Score
MSK Authors
  1. Hani Hassoun
    159 Hassoun